Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. - Wikidata - awgldk - TriplyDB

Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.

Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.

http://www.wikidata.org/entity/Q40545056

about

KASL clinical practice guidelines: management of chronic hepatitis B Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine Evolution of hepatitis B management in kidney transplantation Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients.Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients Immune response to hepatitis B vaccine among patients on hemodialysis Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections Efficacy of HBV vaccination in various stages of chronic kidney disease: is earlier better?The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease.Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.A randomized controlled trial of two schedules of hepatitis B vaccination in predialysed chronic renal failure patients KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature.Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population.Sex bias in response to hepatitis B vaccination in end-stage renal disease patients: Meta-analysis.Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients.Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.New hepatitis B vaccine formulated with an improved adjuvant system.Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients Vaccine-Induced Anti-HBs Level in 5-6 Year-Old Malnourished Children."Let there be light": the role of vitamin D in the immune response to vaccines.Epidemiology of acute infections among patients with chronic kidney disease The relationship between erythropoietin resistance and antibody response to hepatitis B vaccine in hemodialysis patients.Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients.Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.Meta-analysis: the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease.Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis.Immunization in end-stage renal disease: opportunity to improve outcomes.Vaccination issues in patients with chronic kidney disease.Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines.In reply to "the relationship between erythropoietin resistance and antibody response to hepatitis B vaccine in hemodialysis patients".Variability in response to hepatitis B vaccine in hemodialysis patients.A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B(®), among vaccine naïve and vaccine non-responder dialysis patients.Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: a systematic review and meta-analysis.[Guidelines for vaccination of immunocompromised individuals].

P2860

Q26752475-83842FBF-D837-4BC4-9869-4640A19E7C7C Q26777516-8E30FD60-29CC-4D41-8215-2C060443C03B Q26995706-D2228C41-BEBD-4EE5-993D-CDAAB743ABAC Q30424358-E6190CE9-7B59-4F04-B118-2474E66FC896 Q34168451-30D6A93C-EC61-4E4F-99A8-F2CA2C3A517E Q35127054-A4F795F2-6B8B-4483-99F5-A67749E2A666 Q35532440-B485C364-DAC0-4CD2-827E-CCAAEEAF65AB Q35603817-0087E623-64C4-4128-9FCC-4D6C23AB9856 Q35633471-37EB9422-10C0-4E94-B0A5-5FCBDEF6CFD8 Q35878625-9E399AE9-C1AE-41DB-A514-8D4835D4B972 Q35966083-73C02D26-18A2-472C-B1C6-B822F2C7851A Q36075066-B5C8E924-A118-4447-A5C8-4CFEEB2FF429 Q36153966-A39DBC0E-EC3A-42A6-842D-1FB5D827F6F1 Q36426868-2FFD23DF-6989-4BFE-901B-B09AF59F3C65 Q36447572-9B8A4CD9-A04D-4504-8458-5C4E05702139 Q36447927-C01FA5C8-E944-4314-A095-7B935DB848AE Q36476772-5EBBBE28-BB98-4EF8-BEE9-DE9145868815 Q36537647-6234A10B-2731-4B4C-8CCE-1D2B4A7D1420 Q36555974-C4BE517B-69B5-4629-BD47-FCE538B890D1 Q36570811-5EDC7DB4-2DC1-493B-AF75-F7E554FEE5E3 Q36780117-0DDBE2A3-76BE-4B11-9D04-2C7C95FB3901 Q36789845-9A05C31E-DAA0-4184-87A3-F7E6293EA85E Q36796786-234CFB6E-F5F0-411C-8797-0E124CB89BDC Q36816598-8E8E7F6D-1C51-4D64-AD09-1C6B02808AC9 Q37020161-B26DEF19-374A-402D-989C-9D9A9B8A9387 Q37225033-87B140AD-96F6-4439-8E9C-A3887B76B2EF Q37316457-7EB60822-576B-4E19-B29E-1979FE0EF4EC Q37428668-F0CAE05C-5945-4E78-8CCA-969E2CB5AC3E Q37833653-B60A54F9-EE11-464A-BB86-8AC32E067E66 Q37957298-88A46B63-4280-48C5-82AE-2749D7626042 Q37964987-4EBE56B3-D7A1-4D86-AE48-EF4AAECD6D95 Q38027684-A28D5B5D-6132-481A-A04E-4F601F4319FF Q38113298-036DC38C-D098-47F7-A9DF-30167163A3AC Q38176987-DCB072FC-BB2D-44D7-B6E0-70C9A95B9C30 Q38242238-3FD00434-9EF8-4930-8F4C-F25F1F47358F Q38282755-81FB8B50-BEB8-41F0-9D2D-DB964F35E770 Q38381162-4339052E-A68B-44E7-ABC1-1D6AEDEAD830 Q38689359-E8DD1BA0-9711-47AD-A1EC-B3C9357A4391 Q38695671-0EE9F40B-9FD5-48D3-8453-0AE98896061A Q40600058-B623AD94-3F30-40A7-9496-B582C8EAF728

P2860

Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.

http://www.wikidata.org/entity/Q40545056

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Stage of chronic kidney diseas ...... munization: earlier is better.

@en

type

label

Stage of chronic kidney diseas ...... munization: earlier is better.

@en

prefLabel

Stage of chronic kidney diseas ...... munization: earlier is better.

@en

P1433

Q40545056-EE130426-E6AD-4EE6-9017-CD6C56B887DD

P1476

Q40545056-89959012-E159-462F-90D5-C6A4F4D8CA92

P2093

Q40545056-1B60DB21-8475-4150-96D5-C2E6E90BF6BC

Q40545056-2214E65B-7E79-48DF-BBEC-805DBD6571A8

Q40545056-5361C95A-B031-41C2-8A1A-4C0350C57A6A

Q40545056-6A228506-263D-425D-BB54-D55F93C19D60

Q40545056-720A0760-745A-4913-BF7F-321C7D207374

Q40545056-851649B9-AA89-4B69-815A-F8C159A0E71B

Q40545056-8DE63A18-94BD-4C6D-9B4C-DCAA5B032800

Q40545056-B253C089-FFEA-4AE9-9AE2-CA3E951D2D53

Q40545056-C923A55E-E937-4B85-B5D5-F4266E141E5B

P304

Q40545056-137A72AC-4FC3-4815-8A60-CF0110CF18CF

P31

Q40545056-8F29BCC2-F951-46B0-BDD3-7CF39E5CD5DF

P356

Q40545056-8C6DF82F-2DBD-4072-A416-97AFEBCF4555

P433

Q40545056-27045465-F478-4215-9899-AD0F071E87D5

P478

Q40545056-5DB79E7F-FD62-45C7-9B5E-D16571EA5527

P577

Q40545056-A761F13A-1F1C-4F6D-8C3D-8E70B94FF2D6

P698

Q40545056-993541BC-EFD1-4532-B910-6CEAE8B8E414

P921

Q40545056-34B7A58B-AC10-42A4-B690-A5F280B3E431

Q40545056-A5F0957B-B351-4D73-850A-A76094CC1B24

P356

J.AJKD.2003.08.019

P1433

American Journal of Kidney Diseases

P1476

Stage of chronic kidney diseas ...... munization: earlier is better.

@en

P2093

Adeera Levin

http://www.w3.org/2001/XMLSchema#string

Andrea Loewen

http://www.w3.org/2001/XMLSchema#string

Cathy Kempston

http://www.w3.org/2001/XMLSchema#string

Gerald DaRoza

http://www.w3.org/2001/XMLSchema#string

Janet Love

http://www.w3.org/2001/XMLSchema#string

Mercedeh Kiaii

http://www.w3.org/2001/XMLSchema#string

Ognjenka Djurdjev

http://www.w3.org/2001/XMLSchema#string

Paul A Taylor

http://www.w3.org/2001/XMLSchema#string

Shelley Burnett

http://www.w3.org/2001/XMLSchema#string

P304

1184-1192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2003.08.019

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14655190

http://www.w3.org/2001/XMLSchema#string

P921